The Utility of Delayed-Enhancement and T2-Weighted Cardiovascular MRI for Predicting Clinical Outcomes in Patients at High Risk for Cardiac Sarcoidosis

Vorasettakarnkij, YongkasemMedina, Hector MAhmed, WaleedHolmvang, GodtfredDeeprasertkul, PeerawutVerdini, Daniel JUthamalingam, ShanmugamBrady, ThomasGhoshhajra, BrianSosnovik, David2012-03-012011Vorasettakarnkij, Yongkasem, Hector M. Medina, Waleed Ahmed, Godtfred Holmvang, Peerawut Deeprasertkul, Daniel J. Verdini, Shanmugam Uthamalingam, Thomas J. Brady, Brian B. Ghoshhajra, and David E. Sosnovik. 2011. The utility of delayed-enhancement and t2-weighted cardiovascular mri for predicting clinical outcomes in patients at high risk for cardiac sarcoidosis. Journal of Cardiovascular Magnetic Resonance 13(Suppl 1): O105.1097-6647http://nrs.harvard.edu/urn-3:HUL.InstRepos:8296039en-USThe Utility of Delayed-Enhancement and T2-Weighted Cardiovascular MRI for Predicting Clinical Outcomes in Patients at High Risk for Cardiac SarcoidosisResearch Paper or Report2012-03-0110.1186/1532-429X-13-S1-O105